v

COVID-19 to delay clinical trials

Drugmakers want to keep trials going but acknowledge that medical resources are strained




v

With COVID-19 mostly behind it, China's chemical industry struggles to rev up

Lingering logistic problems and a sputtering economy mean hard times for companies




v

Journal publishers promote flexibility during COVID-19 pandemic

Editors in Europe and the US plan to work with authors whose lives and labs have been disrupted by the novel coronavirus




v

Elusive phosphorus compound synthesized

Long-sought phosphatetrahedrane could lead to new organophosphorus compounds




v

Is a reagents shortage delaying European COVID-19 testing?

Fingers are being pointed in the Netherlands and the UK over reagent capacity constraints




v

CAS curates dataset of antiviral compound leads with potential activity against COVID-19

Open-access collection contains nearly 50,000 chemical compounds from the CAS Registry




v

Trump's science adviser leads NSF temporarily

Kelvin Droegemeier takes over the agency until Congress confirms nominee




v

Covestro borrows $240 million for sustainability R&D




v

Life sciences consortium connects with Gates Foundation to tackle COVID-19




v

Chemical industry welcomes leniency from US EPA during coronavirus response

Activists say broad lack of enforcement threatens safety




v

US stimulus bill includes funding for coronavirus research

The National Institutes of Health receives the vast majority of the support




v

J&J and BARDA advance coronavirus vaccine




v

Sanofi and Translate Bio add coronavirus to vaccine pact




v

Video: Chemistry turns backyard clay into a 3-D printable building material

Technology could reduce the environmental impact of 3-D printed buildings by adapting locally harvested soils




v

Novel coronavirus thought to have jumped to humans via pangolins

Trafficked scaly anteaters found to carry coronaviruses related to SARS-CoV-2




v

Will the coronavirus help mRNA and DNA vaccines prove their worth?

As gene-based vaccines are being designed and tested at unprecedented speeds to fight COVID-19, scientists wonder if this will be the technology's make-or-break moment.




v

Meet Sheng Ding, who is tackling COVID-19 as director of China's Global Health Drug Discovery Institute

The chemist wants the Gates Foundation–backed institute to share its expertise during the coronavirus pandemic and advocate for public health




v

Grad students tell of the coronavirus's impact

Delayed postdoc opportunities. Canceled commencement. Graduate students in chemistry describe how the COVID-19 pandemic has affected their work and lives




v

Chemistry faculty cope with coronavirus shutdowns

With university labs shuttered by COVID-19, chemistry faculty are getting a crash course in how to stay productive




v

Trump's science adviser leads NSF temporarily

Kelvin Droegemeier takes over the agency until Congress confirms nominee




v

Plastic bag bans rolled back for COVID-19

Regulators are restricting reusable bags over worries they might harbor virus




v

Clinical trial for ruxolitinib planned in fight against COVID-19

Treatment for rare blood cancers could temper cytokine storm in people with severe forms of the disease




v

How the coronavirus will transform science

Thought leaders in life sciences weigh in on lessons learned amid the COVID-19 pandemic




v

Searching for a coronavirus cure in the blood

Scientists look to convalescent plasma, hyperimmune therapy, and monoclonal antibodies to treat COVID-19




v

Why the best material for a homemade coronavirus face mask is hard to identify

Variables in fabrics, fit, and user behavior can influence how well a mask might block the virus's spread




v

European Research Council president resigns amid dispute over coronavirus response

Mauro Ferrari quits after three months at the helm




v

How a SARS patient's antibody binds to the COVID-19 virus

Structural data on the complex could guide drug and vaccine design




v

Why the best material for a homemade coronavirus face mask is hard to identify

Variables in fabrics, fit, and user behavior can influence how well a mask might block the virus's spread




v

Plastic bag bans rolled back for COVID-19

Regulators are restricting reusable bags over worries they might harbor virus




v

Clinical trial for ruxolitinib planned in fight against COVID-19

Treatment for rare blood cancers could temper cytokine storm in people with severe forms of the disease




v

US EPA advances rollbacks while coronavirus pandemic rages

Work continues on chemical risks, climate, and what data regulators may consider




v

Coronavirus puts science to the test

A new generation of technologies being used for the diagnosis, treatment, and prevention of COVID-19 will be pressure tested amid a pandemic




v

Industry requests safety review of cyclic siloxane

US EPA considers evaluating risks of D4 under the Toxic Substances Control Act




v

Virus weakens markets for renewable energy

Industries press pause on steep growth trajectory




v

Rgenta Therapeutics launches with $20 million to develop small molecules that target RNA




v

Podcast: The chemist who helped save Apollo 13

<i>Stereo Chemistry</i> reveals the surprising origin story of the engine that brought the Apollo 13 astronauts home and the man who designed it




v

Merdad Parsey on building a case for remdesivir amid the coronavirus pandemic

Gilead's Chief Medical Officer talks about the challenges of clinical design in the time of COVID-19




v

How susceptible is your cat or dog to the novel coronavirus?

Cats can transmit SARS-CoV-2 to one another, but the virus replicates poorly in dogs, pigs, chickens, and ducks, study finds




v

Amgen and Adaptive pursue COVID-19 antibody therapy




v

GSK partners with Vir on COVID-19 therapies and with 3 companies on vaccines




v

Carbon rolls out 3-D printing for COVID-19




v

Nova slows projects due to COVID-19




v

Low-cost perovskite detects X-rays sensitively

Made and processed via wet chemistry, the inexpensive material could improve radiation safety




v

Pentachlorophenol is on its way out as a utility pole preservative. Here's what might take its place

Phaseout is pushing a slow-to-change industry to look at alternatives




v

Por que o melhor material para uma m&#225;scara facial caseira para o coronav&#237;rus &#233; dif&#237;cil de identificar

Variáveis em tecidos, ajuste e comportamento do usuário podem influenciar a eficácia com que uma máscara pode bloquear a propagação do vírus




v

What do we know about the novel coronavirus's 29 proteins?

These biomolecules could hold clues to why the virus is so infectious and how to stop it




v

Fujifilm tests favipiravir as COVID-19 treatment

Japanese government plans to buy at least 2 million tablets of the influenza drug




v

Chemistry in Pictures: Somewhere over the rainbow




v

What explains the non-respiratory symptoms seen in some COVID-19 patients?

Some patients experience neurological, cardiovascular, and intestinal symptoms after infection with SARS-CoV-2




v

To improve safety, Camille Peres couples psychology to process design

People are too complicated for one-size-fits-all communication, she says